"nemocnica"

During the past decade, Narodny ustav detskych chorob conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Narodny ustav detskych chorob" #1 sponsor was "Pfizer" with 8 trials, followed by "Bayer" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Dermatology Specialties Limited Partnership" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodny ustav detskych chorob" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Children's Oncology Group (COG)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Narodny ustav detskych chorob" are "Retinopathy of Prematurity (ROP)" (2 trials), "Candidiasis" (1 trials), "Colitis, Ulcerative" (1 trials), "Crohn's Disease (CD)" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Narodny ustav detskych chorob" in a lesser frequency.

Most popular intervention types in "Narodny ustav detskych chorob" are "Drug" (13 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eylea (Aflibercept, BAY86-5321)" (2 trials), "Laser photocoagulation" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narodny ustav detskych chorob" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Narodny ustav detskych chorob". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Narodny ustav detskych chorob, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Narodny ustav detskych chorob, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".